CINAPSIS NEUROSCIENCE is a Company that is engaged in the discovery, development and commercialization of innovative therapeutic approaches designed to treat pediatric and adult neurological disorders such as Autism, ADD, Stroke and Brain Injury. The Company believes that its efforts may deliver proprietary next-generation therapies, such as multisensory stimulation therapies, neuromodulation therapies and multisensory processing research.  These therapeutic approaches are directed toward changing the way that the brain processes sensory information.